Efficacy and Safety of IQYMUNE®, a Ten Percent Intravenous Immunoglobulin in Adult Patients With Chronic, Primary Immune Thrombocytopenia

BACKGROUND: Intravenous immunoglobulin (IVIG) IQYMUNE® is a highly purified 10% IVIG that was assessed using the new stringent definition of response described in the revised guideline on the clinical investigation of IVIG. The efficacy and the safety of IQYMUNE® were investigated in adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodeghiero, Francesco, Woszczyk, Dariusz, Slama, Borhane, Melikyan, Anait, Viallard, Jean-Francois, Ouaja, Rabye, Cisse, Ousmane Alfa, Sadoun, Alain, Salama, Abdulgabar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155829/
https://www.ncbi.nlm.nih.gov/pubmed/32300420
http://dx.doi.org/10.14740/jh385w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155829/
https://www.ncbi.nlm.nih.gov/pubmed/32300420
http://dx.doi.org/10.14740/jh385w

Ejemplares similares